ALZH DEMENT-DADM 潤色咨詢

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING

出版年份：2015 年文章數(shù)：505 投稿命中率： 開通期刊會員，數(shù)據(jù)隨心看

出版周期：Annual 自引率：暫無數(shù)據(jù) 審稿周期： 開通期刊會員，數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿周期
開通期刊會員，數(shù)據(jù)隨心看
我要補充
投稿命中率
開通期刊會員，數(shù)據(jù)隨心看
我要補充
審稿費用
暫無數(shù)據(jù)
我要補充
版面費用
暫無數(shù)據(jù)
我要補充
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量暫無數(shù)據(jù) (2022年為0.84%)
自引率
暫無數(shù)據(jù)
年文章數(shù)
505
期刊官網(wǎng)
點擊查看 (點擊次數(shù):547)
我要修改
投稿鏈接
點擊查看 (點擊次數(shù):432次)
我要修改
作者需知
點擊查看 (點擊次數(shù):982次)
我要修改
NCBI查詢
PMC鏈接 | Pubmed全文檢索
偏重的研究方向
暫無數(shù)據(jù)
我要補充
期刊簡介
稿件收錄要求

lzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring?(DADM)?is an open access journal that concentrates on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers, ranging from gene expression and proteomic markers, to imaging, cognitive and functional markers of disease progression or treatment response. Review our?Author Guidelines?and submit your?manuscript?to?DADM.

DADM?is now indexed in the Emerging Sources Citation Index (ESCI).


?Reasons to Publish with Us:

  • Easy to follow Author Guidelines with expedient time to first decision and online publication.
  • Broad editorial team allows us to match your article with a skilled reviewer in your content area.
  • Open Access format makes your research free to read and share, with author copyright retention.
  • Publishes high-interest Special Topic Sections anually, and has a CiteScore over 7.
?
常用鏈接
期刊論壇 | 中國SCI論文 | 期刊介紹 | 投稿信息 | 雜志官網(wǎng) | 投稿鏈接 | 作者需知 | PMC鏈接 | Pubmed全文檢索